SR

Smita Rajeev Singh

Director Director DIN 08038499
DIN 08038499 First appointment Dec 2018 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2018
Shareholding value Locked Premium profile

About Smita Rajeev Singh

Smita Rajeev Singh has 7 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 08038499
Primary Designation Director
First Appointment 13 Dec 2018
Oldest Company Age 7 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Zeefame Pharma Private Limited U74999GJ2018PTC105604
Director 13 Dec 2018 2018 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Zeefame Pharma Private Limited
Premium access

Shareholding and investment profile for Smita Rajeev Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Smita Rajeev Singh

Smita Rajeev Singh has 7 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Smita Rajeev Singh is associated with 0 companies as Director.

Smita Rajeev Singh has expertise in General Business.

Smita Rajeev Singh has 7 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available